Key result
100% systolic blood pressure time in target range <140 mmHg was associated with a reduced risk of incident cardiovascular disease compared to 0% TTR (HR 0.81; 95% CI 0.68-0.96; P=0.01).
Why the study?
Blood pressure time in target range predicts cardiovascular disease in high-risk populations, but its predictive utility in older adults without prior CVD remains uncertain.
Does a higher systolic blood pressure time in target range reduce the risk of cardiovascular events in older adults without prior cardiovascular disease?
Cohort (n=16,730)
Does a higher systolic blood pressure time in target range reduce the risk of cardiovascular events in older adults without prior cardiovascular disease?
Hazard Ratio: 0.81 (95% CI 0.68–0.96)
p-value: p=.01
In older adults without prior cardiovascular disease, maintaining systolic blood pressure consistently in target range (<130 or <140 mmHg) is associated with a significantly reduced risk of incident CVD and MACE.
Sustained BP control may lower CVD risk in older adults without prior CVD; leaves open whether TTR-guided strategies improve outcomes.
BACKGROUND: Blood pressure (BP) time in target range (TTR) predicts cardiovascular disease (CVD) in high-risk populations; however, TTR's predictive utility in older adults without prior CVD is uncertain. METHODS: We performed a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial and its observational follow-up. Systolic BP TTR for <140 and <130 mmHg was estimated for each participant using BPs from the first three visits. Participants with 0% or 100% TTR were categorized separately, and remaining participants grouped into tertiles using linear interpolation to estimate TTR. Cox proportional hazards models evaluated associations between TTR and adjudicated incident CVD and major adverse cardiovascular events (MACE) after the TTR estimation period, with 0% TTR as reference. RESULTS: Among 16,730 predominantly white Australian adults (mean age, 74 years) followed for a mean of 7.7 years after TTR estimation, 100% TTR <140 mmHg had reduced risk of CVD (HR, 0.81 [95% CI, 0.68-0.96]; P = .01), while 100% TTR <130 mmHg had reduced risks of CVD (HR, 0.82 [95% CI, 0.67-0.99]; P = .04) and MACE (HR, 0.72 [95% CI, 0.57-0.91]; P < .01). Associations were strongest among women, antihypertensive users, frail/pre-frail participants, and those younger than median age. Findings were consistent after adjusting for competing risk of non-CVD death, when the TTR estimation period was extended an additional year, and when estimated using proportion of individual visit BPs at target. CONCLUSIONS: Longer systolic BP TTR was associated with reduced risk of cardiovascular events in older adults, underscoring the importance of sustained BP control with aging.
No takes yet. Share an insight, caveat, or question.
Ernst et al. (2026) conducted a cohort in older adults without prior CVD (n=16,730). 100% systolic BP time in target range (TTR) <140 mmHg vs. 0% TTR was evaluated on incident CVD (HR 0.81, 95% CI 0.68-0.96, p=.01). 100% systolic blood pressure time in target range <140 mmHg was associated with a reduced risk of incident cardiovascular disease compared to 0% TTR (HR 0.81; 95% CI 0.68-0.96; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: